NEW YORK, Feb. 10, 2024 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Karuna Therapeutics, Inc. (NASDAQ: KRTX)’s sale to Bristol Myers Squibb for $330.00 per share in cash. If you are a Karuna shareholder, click here to learn more about your rights and options.
Daseke, Inc. (NASDAQ: DSKE)’s sale to TFI International Inc. for $8.30 in cash per common share. If you are a Daseke shareholder, click here to learn more about your rights and options.
United States Steel Corporation (NYSE: X)’s sale to Nippon Steel Corporation for $55.00 per share. If you are a U. S. Steel shareholder, click here to learn more about your rights and options.
RayzeBio, Inc. (NASDAQ: RYZB)’s sale to Bristol-Myers Squibb Company for $62.50 per share in cash. If you are a RayzeBio shareholder, click here to learn more about your rights and options.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
Originally published at https://www.einpresswire.com/article/687696354/shareholder-update-halper-sadeh-llc-investigates-krtx-dske-x-ryzb
